Health
Biocompatible photooxygenation catalyst could be potentially used to treat amyloid diseases – News-Medical.Net
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer’s disease (AD)-related amyloid-β…
Reviewed by Emily Henderson, B.Sc.Nov 25 2020
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer’s disease (AD)-related amyloid-β peptide (Aβ) under near-infrared (NIR) light irradiation is developed.
The catalyst was able to oxygenate Aβ embedded under the skin of a living mouse, and diminished intact Aβ level in AD-model mouse brain. The new catalyst is potentially applicable for the treatment of peripheral amyloid…
-
General18 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News23 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
General19 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News9 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones